Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Feasibility and Long Term Outcome

NCT01902238 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01902238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01902238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Feasibility and Long Term Outcome
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
August 31, 2017
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, feasibility, safety